Form 4: Sabra Health Care Director Acquires Stock Units
Insider Transaction Report
Sabra Health Care REIT Director Lynne S. Katzmann acquired 808 common stock units as dividend equivalents, increasing her total beneficial ownership to 76,213 shares.
Summary
- Lynne S. Katzmann, a Director of Sabra Health Care REIT, Inc. (SBRA), acquired 808 shares of common stock.
- The transaction date for this acquisition is reported as November 28, 2025.
- These 808 shares represent stock units credited to Ms. Katzmann as dividend equivalent payments on previously granted stock units under the Issuer's 2009 Performance Incentive Plan.
- The stock units were acquired at a price of $0, indicating they are part of a compensation or dividend distribution rather than a direct purchase.
- These newly acquired units will vest and become payable on the same terms as the original stock units to which they relate.
- Following this transaction, Ms. Katzmann's direct beneficial ownership totals 76,213 shares.
- This total beneficial ownership includes 4,921 unvested stock units and 48,497 stock units that have vested but whose payment has been deferred.
- Each stock unit represents the right to receive one share of the Issuer's Common Stock.
- The transaction was made pursuant to a contract, instruction, or written plan for the purchase or sale of equity securities of the issuer, intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Sentiment
Score: 6
Explanation: The filing reports a routine, pre-scheduled acquisition of stock units by a director as part of their compensation, which is a neutral to slightly positive event. It increases director ownership, aligning interests with shareholders, and is consistent with standard corporate compensation practices. The future transaction date is explained by the 10b5-1 plan.
Positives
- The acquisition of stock units by a director increases their beneficial ownership, aligning their interests more closely with those of shareholders.
- The receipt of dividend equivalent payments on existing stock units indicates ongoing value generation from previously awarded compensation.
Future Outlook
The acquired stock units will vest and become payable on the same terms as the original stock units to which they relate, indicating future share distributions upon meeting vesting conditions.
Industry Context
This is a routine insider transaction, common in the REIT sector and across publicly traded companies, where directors receive equity compensation, often including dividend equivalents on previously granted awards, to align their interests with long-term shareholder value.
Comparison to Industry Standards
- The practice of granting stock units and dividend equivalents to directors is a standard component of executive and director compensation packages across various industries, including healthcare REITs, to incentivize long-term performance and align interests with shareholders.
- The use of a Rule 10b5-1 plan for pre-scheduled transactions is a common corporate governance practice to allow insiders to trade company stock without concerns of insider trading, providing transparency and predictability.
Stakeholder Impact
- Shareholders: The increase in director ownership through stock units generally aligns the director's financial interests with those of the shareholders, potentially fostering long-term value creation.
Next Steps
- The acquired stock units will vest and become payable according to the terms of the original stock units under the Issuer's 2009 Performance Incentive Plan.
Key Dates
| Date | Description |
|---|---|
| 11/28/2025 | Transaction date for the acquisition of 808 common stock units by Director Lynne S. Katzmann. |
| 12/02/2025 | Date the Form 4 filing was signed by Michael Costa, as Attorney-in-Fact. |
Recommendation
holdThis Form 4 filing details a routine, pre-scheduled acquisition of stock units by a director as part of their compensation plan. While it slightly increases insider ownership, which is generally a positive signal for alignment, it does not present new material information that would significantly alter the investment thesis for Sabra Health Care REIT. It is a standard disclosure of a non-discretionary transaction, thus warranting a 'hold' recommendation as it provides no strong catalyst for a 'buy' or 'sell' decision based solely on this filing.
Keywords
Sabra Health Care REIT, SBRA, Lynne S. Katzmann, Director, Stock Units, Dividend Equivalents, Insider Transaction, Form 4, Beneficial Ownership, 10b5-1 Plan
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.